RGC – Regencell Bioscience Holdings Ltd
RGC — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
0.62
Margin Of Safety %
Put/Call OI Ratio
1.06
EPS Next Q Diff
EPS Last/This Y
EPS This/Next Y
Price
4.91
Target Price
Analyst Recom
Performance Q
-7.66
Upside
-105.3%
Beta
1.75
Ticker: RGC
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-10-15 | RGC | 9.4 | 1.31 | 0.37 | 6634 |
| 2026-10-16 | RGC | 9.63 | 1.03 | 0.91 | 8856 |
| 2026-10-19 | RGC | 10.09 | 2.14 | 1.40 | 4758 |
| 2026-10-20 | RGC | 10.36 | 1.46 | 2.25 | 4309 |
| 2026-10-21 | RGC | 10.87 | 1.67 | 0.12 | 4441 |
| 2026-10-22 | RGC | 9.85 | 1.63 | 0.05 | 4503 |
| 2026-10-23 | RGC | 7.61 | 1.73 | 0.01 | 4406 |
| 2026-10-26 | RGC | 6.75 | 1.64 | 0.06 | 4499 |
| 2026-10-27 | RGC | 7.45 | 1.52 | 0.02 | 4637 |
| 2026-10-28 | RGC | 7.33 | 1.56 | 0.00 | 4590 |
| 2026-10-29 | RGC | 6.83 | 1.42 | 0.00 | 4761 |
| 2026-10-30 | RGC | 6.61 | 1.40 | 0.00 | 4794 |
| 2026-11-02 | RGC | 6.25 | 1.41 | 0.00 | 4786 |
| 2026-11-03 | RGC | 6.1938 | 1.41 | 0.00 | 4787 |
| 2026-11-04 | RGC | 5.39 | 1.40 | 0.25 | 4788 |
| 2026-11-05 | RGC | 5.27 | 1.37 | 1.67 | 4801 |
| 2026-11-06 | RGC | 5.32 | 1.38 | 29.00 | 4818 |
| 2026-11-09 | RGC | 5.595 | 1.01 | 2.37 | 4111 |
| 2026-11-10 | RGC | 5.24 | 1.03 | 95.00 | 4160 |
| 2026-11-11 | RGC | 5.42 | 1.08 | 0.95 | 4254 |
| 2026-11-12 | RGC | 5.14 | 1.07 | 0.05 | 4312 |
| 2026-11-13 | RGC | 5.02 | 1.06 | 0.06 | 4318 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-10-15 | RGC | 9.36 | - | - | - |
| 2026-10-16 | RGC | 9.61 | - | - | - |
| 2026-10-19 | RGC | 10.10 | - | - | - |
| 2026-10-20 | RGC | 10.10 | - | - | - |
| 2026-10-21 | RGC | 10.41 | - | - | - |
| 2026-10-22 | RGC | 9.85 | - | - | - |
| 2026-10-23 | RGC | 7.61 | - | - | - |
| 2026-10-26 | RGC | 6.78 | - | - | - |
| 2026-10-27 | RGC | 7.41 | - | - | - |
| 2026-10-28 | RGC | 7.20 | - | - | - |
| 2026-10-29 | RGC | 6.85 | - | - | - |
| 2026-10-30 | RGC | 6.66 | - | - | - |
| 2026-11-02 | RGC | 6.27 | - | - | - |
| 2026-11-03 | RGC | 6.11 | - | - | - |
| 2026-11-04 | RGC | 5.41 | - | - | - |
| 2026-11-05 | RGC | 5.26 | - | - | - |
| 2026-11-06 | RGC | 5.32 | - | - | - |
| 2026-11-09 | RGC | 5.62 | - | - | - |
| 2026-11-10 | RGC | 5.24 | - | - | - |
| 2026-11-11 | RGC | 5.45 | - | - | - |
| 2026-11-12 | RGC | 5.16 | - | - | - |
| 2026-11-13 | RGC | 4.91 | - | - | - |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-10-15 | RGC | 0.00 | 63.32 | 1.17 |
| 2026-10-16 | RGC | 0.00 | 63.32 | 1.17 |
| 2026-10-19 | RGC | 0.00 | 63.32 | 1.17 |
| 2026-10-20 | RGC | 0.00 | 63.32 | 1.17 |
| 2026-10-21 | RGC | 0.00 | 63.32 | 1.17 |
| 2026-10-22 | RGC | 0.00 | 63.32 | 1.17 |
| 2026-10-23 | RGC | 0.00 | 63.32 | 1.17 |
| 2026-10-26 | RGC | 0.00 | 63.29 | 1.17 |
| 2026-10-27 | RGC | 0.00 | 63.29 | 0.78 |
| 2026-10-28 | RGC | 0.00 | 63.29 | 0.78 |
| 2026-10-29 | RGC | 0.00 | 63.29 | 0.78 |
| 2026-10-30 | RGC | 0.00 | 63.29 | 0.78 |
| 2026-11-02 | RGC | 0.00 | 64.45 | 0.78 |
| 2026-11-03 | RGC | 0.00 | 64.45 | 0.78 |
| 2026-11-05 | RGC | 0.00 | 64.45 | 0.78 |
| 2026-11-06 | RGC | 0.00 | 64.45 | 0.78 |
| 2026-11-09 | RGC | 0.00 | 63.18 | 0.78 |
| 2026-11-10 | RGC | 0.00 | 63.18 | 0.78 |
| 2026-11-11 | RGC | 0.00 | 63.18 | 0.62 |
| 2026-11-12 | RGC | 0.00 | 63.18 | 0.62 |
| 2026-11-13 | RGC | 0.00 | 63.18 | 0.62 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
Avg. EPS Est. Current Quarter
Avg. EPS Est. Next Quarter
Insider Transactions
Institutional Transactions
63.18
Beta
1.75
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
8
Growth Score
Sentiment Score
24
Actual DrawDown %
94.1
Max Drawdown 5-Year %
-93.9
Target Price
P/E
Forward P/E
PEG
P/S
P/B
183.51
P/Free Cash Flow
EPS
-0.02
Average EPS Est. Cur. Y
EPS Next Y. (Est.)
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
0.49
Return on Equity vs Sector %
-100
Return on Equity vs Industry %
-94.4
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
◆
RGC
Healthcare
$4.94
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
34.5
Range 1M
2.1%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
0%
EPS NY
0%
52W%
0.6%
Long-Term Value
Quality companies, undervalued
WEAK
Quality
8
RGC — P/E HistoricalDrug Manufacturers - Specialty & Generic
Regencell Bioscience Holdings LSector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 10
Regencell Bioscience Holdings Limited focuses on the research, development, and commercialization of Traditional Chinese Medicine (TCM) in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, TCM brain theory, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
RGC
Latest News
—
Caricamento notizie per RGC…
stock quote shares RGC – Regencell Bioscience Holdings Ltd Stock Price stock today
news today RGC – Regencell Bioscience Holdings Ltd stock forecast ,stock prediction 2023 2024 2025
marketwatch RGC – Regencell Bioscience Holdings Ltd yahoo finance google finance
stock history RGC – Regencell Bioscience Holdings Ltd invest stock market
stock prices RGC premarket after hours
ticker RGC fair value insiders trading